How hospice became big business. A new investigation in The New Yorker reveals an industry that at times puts profits before patients.
Diane talks with two experts about the latest decisions from the Supreme Court allowing judges to determine who is allowed to testify as an "expert" scientific witness and who is not. This decision can determine what testimony juries will hear in liability and medical malpractice cases. The panel talks about the increasing importance of expert witnesses in trials, and the consequences of trying to keep "junk science" out of the courtroom.
- Fred Baron President of the Association of Trial Lawyers of America
- Peter Huber Senior fellow at the Manhattan Institute and author, with Kenneth R. Foster, of "Judging Science" (MIT Press)
Most Recent Shows
Pulitzer Prize-winning biographer Jon Meacham on the evolution of Abraham Lincoln's moral principles and political leadership -- and what the era of Lincoln can teach us about the state of our democracy today.
What troubles at Twitter say about the state of social media -- and why one tech watcher argues this could transform the industry in positive ways.
Political analyst Norman Ornstein on control of Congress, the red wave that wasn't, and other lessons from the midterm elections.